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INTRODUCTION
The levels of plasma osmolality and sodium ion are main-
tained by regulation of hypothalamic osmoreceptor, which
controls water intake and vasopressin release. Temporal hy-
pernatremia after hypothalamic surgery or trauma can be
observed with various degrees of anti-diuretic hormone
(ADH) deficiency. However, persistent hypodipsia and
hypernatremia associated with anatomical lesions in the
hypothalamic area is an uncommon syndrome. Although
there have been additional reports (1-18) since Schaad et al.
(19) described patients with  “hypodipsia-hypernatremia”
in 1979, this is the first case report in Korea. Abnormal
ADH secretion was demonstrated in some cases of hypodip-
sic hypernatremia. Some showed normally regulated ADH
secretion by serum osmolality but others have shown the
ADH secretion was dependent on non-osmotic, almost
hemodynamic stimuli only. We report a case of chronic
hypodipsic hypernatremia with an intact ADH response to
non-osmotic stimuli induced by hypothalamic lesions such
as hypothalamic tumor.
CASE REPORT
A 25-yr-old man was admitted for evaluation of asymp-
tomatic hypernatremia. Five years prior to admission, a brain
tumor was found in his thalamus (Fig. 1). It was treated
with 2200 cGy radiation for 2 weeks without prior patho-
logic confirmation. After discharge, the brain tumor was
followed up with brain MRI on a neurosurgical out-patient
basis, which demonstrated a complete regression of the
tumor. Since the development of the disease, hypernatrem-
ia, hyperosmolality, and hypokalemia were sustained but a
proper evaluation was not performed. He never felt thirsty
despite the elevated plasma osmolality and did not drink
spontaneously. He usually refused fluids when they were
offered. Physical and neurological examinations showed
blood pressure at 100/60 mmHg, pulse 76/min, body tem-
perature 37.2℃, weight 86 kg, height 175 cm, and a non-
dehydrated tongue with normal skin turgor. Mental status
was alert and mental function was partially preserved; he
showed intact orientation but had impaired memory and
defect in retention, calculation, and judgement. Mild right
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Hypodipsic Hypernatremia with Intact AVP Response to Non-Osmotic
Stimuli Induced by Hypothalamic Tumor
: A Case Report
Anatomical lesions of hypothalamic area associated with hypodipsic hypernatrem-
ia have been reported only rarely. We report here a case of hypodipsic hyperna-
tremia induced by a hypothalamic lesion. A 25-yr-old man, who had been treated
with radiation for hypothalamic tumor 5-yr before, was admitted for evaluation of
hypernatremia and hypokalemia. He never felt thirst despite the elevated plasma
osmolality and usually refused to drink intentionally. Plasma arginine vasopressin
(AVP) level was normal despite the severe hypernatremic hyperosmolar state and
urine was not properly concentrated, while AVP secretion was rapidly induced by
water deprivation and urine osmolality also progressively increased to the near
maximum concentration range. All of these findings were consistent with an iso-
lated defect in osmoregulation of thirst, which was considered as the cause of
chronic hypernatremia in the patient without an absolute deficiency in AVP secre-
tion. Hypokalemia could be induced by activation of the renin-angiotensin-aldos-
terone system as a result of volume depletion. However, inappropriately low val-
ues of plasma aldosterone levels despite high plasma renin activity could not
induce symptomatic hypokalemia and metabolic alkalosis. The relatively low
serum aldosterone levels compared with high plasma renin activity might result
from hypernatremia. Hypernatremia and hypokalemia were gradually corrected
by intentional water intake only.
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side motor weakness was also observed. Laboratory data
included a hemoglobin value of 11.9 g/dL, hematocrit 35.3%,
serum creatinine 1.23 mg/dL, uric acid 10.7 mg/dL, BUN
16.6 mg/dL, glucose 102 mg/dL, Na+168 mEq/L, K+3.1
mEq/L, Cl-121 mEq/L, total protein 5.9 g/dL, albumin 3.7
g/dL, osmolality 346 mosm/kg, urine specific gravity 1.020,
urinary Na+132 mEq/L, K+36 mEq/L, osmolality 623
mosm/kg, and TTKG (transtubular K+concentration gra-
dient) 6.4. Thyroid function test was T3 0.72 ng/mL (nor-
mal 0.78 to 1.82), T4 3.12  g/dL (normal 4.68 to 12.48),
TSH 2.3  IU/mL (normal 0.17 to 4.05), and Free T4 0.44
ng/dL (normal, 0.85 to 1.86). Growth hormone (GH) was
0.26 ng/mL (normal, 0.85 to 1.86), prolactin 13.69 ng/mL
(normal, 2 to 15), adrenocorticotropic hormone (ACTH)
35.06 pg/mL (normal, 9 to  52), cortisol 2.74  g/dL (normal,
5 to 25), and testosterone 1.6 ng/mL (normal, 3 to 10). On
the fourth day of admission, a combined pituitary stimula-
tion test was performed. We could predict that hypo-thala-
mic abnormalities were responsible for low end hormone
levels (Table 1). After diagnosis of hypothalamic dysfunc-
tion by combined pituitary function test, glucocorticoid and
thyroid hormone replacement was started. Hormone replace-
Fig. 1. Brain MRI (A) at admission (1995.11.1). There is a large contrast-enhanced mass involving the optic chiasm, hypothalamus, thala-
mi on the left side, and region of the foramen Monroe with extention to the septum pellucidum and anterior horns. (B) Follow-up MRI
(1999.10.24) shows a complete resolution of the previously noted mass in the region of the left basal ganglia. 
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ment did not influence the concentrations of serum elec-
trolytes. We strongly recommended drinking 1.5 L of water
daily. Intentional water intake could elicit the gradual nor-
malization of hypernatremia (Fig. 2).
A water deprivation test was performed on 10th day of
admittance (Table 2). Water deprivation began the night
preceding the test; the patient did not eat anything for 9 hr
before the test. We obtained hourly blood and urine for serum
osmolality, serum sodium, urine osmolality, urine specific
gavity, and urine sodium for 9 hr. Hourly measurements of
body weight, urine volume, and plasma ADH were made,
also. Before the test, plasma ADH level was within the nor-
mal range despite the hypernatremic (155 mEq/L) hyperos-
molality. No vasopressin was administered. However, plas-
ma ADH level was rapidly elevated during water depriva-
tion. Together with the increasing plasma ADH level, urine
osmolality also gradually increased over time.
Evaluation for potassium ion showed that hypokalemia
developed simultaneously with hypernatremia (Table 3).
With hypokalemia, a very high plasma renin activity and
only slightly elevated serum aldosterone levels were observed.
Since his disgnosis of brain tumor in 1995, the patient
had complained of intermittent fever of non-infectious ori-
gin. Under the diagnosis of fever originated from hypotha-
lamic dysfunction, propranolol was administered up to 30
mg every 6 hr (20). However, fever was not controlled to
normal range for 5 days, and we stopped administering pro-
pranolol. He was dischaged on the 26th hospital day with
prescription of a steroid and thyroid hormone replacement,
and was recommended to drink 1.5 L of water per day.
DISCUSSION 
Water balance and osmolality are controlled via hypotha-
lamic integration of signals from osmoreceptors and neu-
rosecretary response with output of vasopressin to various
stimuli. In the maintenance of normal plasma osmolality,
Time GH (ng/mL)
ACTH
(pg/mL)
Cortisol
( g/dL)
Glucose
(mg/dL)
TSH
( IU/mL)
T3
(ng/mL)
free T4
(ng/dL)
Prolactin
(ng/mL)
LH/FSH
(mIU/mL)
Testosterone 
(ng/mL)
Basal 0.33 51.77 4.96 71 1.65 0.72 0.44 21.22 2.93/3.41 1.6
30 min 0.89 66.68 10.47 40 19.68 41.05 43.6/10.3
45 min 0.78 66.69 10.70 105 16.94 37.8 41.8/11.0
Table 1. Combined pituitary stimulation test
A combined pituitary stimulation test was done. We could see that hypothalamic stimulation abnormality was responsible for the low end hormone
level and diagnosed him as tertiary hypothyroidism, tertiary hypogonadism, and tertiary adrenal insufficiency. If he was stimulated with CRH and
GRH, the ACTH and GH levels could be elevated. However, primary GH deficiency could not be completely excluded.
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Fig. 2. The change in serum Na+ level with the amount of water
intake. After daily intake of 2.0 L of water, a change in plasma
Na+ values was observed. Progressive normalization of hyper-
natermia was observed. 
At adm.
19/10/99 
Water drinking
25/10/99
Over night 
fasting start
28/10/99
Dehydration
for 6 hrs
Dehydration 
for 9 hrs
Dehydration
for 12 hrs
Dehydration
for 15 hrs
Serum sodium (mEq/L) 168 155 147 145 144 146 145
Serum osmolality (mOsm/kg) 346 308 292 302 304 294 296
Urine osmolality (mOsm/kg) 623 505 734 702 761 1760 1586
Urine sodium (mEq/L) 132 171 150 91 29 60 45
Urine volume (mL/hr) 700/day 2700/day 50 mL/hr 45 mL/hr 50 mL/hr 20 mL/hr 20 mL/hr
Plasma AVP (nL:1.0-6.7 pg/mL) 1.32 >14.16 >14.16 >14.16 >14.16
Table 2. Water restriction test and serum ADH level
His weight decreased from 81.25 to 79.65 kg (1.98 percent). Contrasting with the data of preceding water deprivation test, serum osmolality and
sodium levels show remarkable changes. Plasma ADH and urine osmolality increased according to the severity of dehydration. Intact ADH secretion
and ability of urine concentration are observed. We could rule out diabetes insipidus.680 M.-J. Kang, K.-H. Yoon, S.-S. Lee, et al.
even a small increase in plasma osmolality triggers two physi-
ologic mechanisms: stimulation of thirst accompanied by
consequent water intake and ADH secretion which increases
renal water reabsorption (1). Patients with decreased men-
tality may become volume-depleted due to the lack of
replacement of insensible water losses. This sequence may
produce hypernatremia because water is lost in proportion
to the excess of sodium (21). However, severe hypernatremia
is not induced if osmoreceptors that respond to hyperosmo-
lality are intact. Anatomical lesions of the hypothalamic area
associated with hypodipsic hypernateremia have been report-
ed only rarely. Hypothalamic dysfunction has been described
most often as it is usually due to tumors, especially germino-
ma, glioma, granulomatous diseases such as sarcoidosis, and
vascular diseases (22, 23).
In this case, the derangement of osmoregulation was in-
duced by a hypothalamic tumor; and radiotherapy of the
tumor resulted in hypodipsia despite the hypernatremia and
hyperosmolality. Water deprivation could elicit an intact
AVP release and normal renal response to AVP (Table 2).
On the basis of these data, we could make a diagnosis of
hypodipsic hypernatremia with intact AVP response to
non-osmotic stimuli induced by a hypothalamic tumor. We
deduced that hypernatremia in this patient developed as
follows: 1) hypodipsia reduced the patient to a mildly dehy-
drated state; 2) the mild hypovolemic state induced sodium
reabsorption by activating the renin-angiotensin-aldos-
terone system; and 3) finally hypernatremia, hypokalemia
and euvolemia were sequentially induced. Due to the
destruction of the hypothal-mic osmoreceptor, the AVP
secretion response to hypernatremia and hyperosmolality
was blunted and hypernatremia progressed. With
hypokalemia, a very high plasma renin activity and only
slightly elevated serum aldosterone levels were observed.
The hypokalemia could be due to the activation of renin-
angiotensin-aldosterone system reflected by high trans-
tubular potassium gradient (TTKG>4). We could observe
parallel fluctuations of the serum sodium and aldosterone
concentrations during the follow-up period (Table 3). These
findings suggest that hypernatremia might play a permis-
sive role in aldosterone secretion (24, 25). Hypokalemia also
appears to contribute to the hypoaldosteronism (12, 26). A
reduction in plasma aldosterone was observed by Crozier et
al. (1986) following intravenous infusion of atrial natriuret-
ic peptide (ANP) wherein the plasma atrial natriuretic pep-
tide (ANP) level was raised to 191 pg/mL. In the present
case, the plasma ANP concentration was 14 pg/mL (nor-
mal, <40) and the ANP-mediated suppression of aldos-
terone secretion appears un-likely. However, normal level of
serum ANP despite severe hypernatremia in the absence of
dehydration may suggest altered ANP regulation in this
patient. This chronic euvolemia and mild hypovolemia can
not stimulate ADH secretion. However, acute dehydration
induced AVP secretion and maintained normonatremic
normoosmolality. Deficiency of AVP secretion was demon-
strated in well-documented cases of hypernatremia, while a
hypernatremic syndrome with absence of thirst, normal,
osmotically regulated vasopressin secretion, and abnormali-
ties of central nervous system was recently observed (28).
Fabris et al. described that their patient falled on the
middle of the spectrum of hypodipsic hypernatremic syn-
drome, that is, between the majority of patients with little
or no osmotically mediated AVP release and the recently
described case of a child, who had a completely normal AVP
secretion (1). It is well known that vasopressin secretion
may not be influenced by osmotic stimulation in hypotha-
lamic anatomical derangement.
According to Robertson et al., osmoreceptors are relatively
insensitive, rather than being reset at a higher level. The
appropriate response in this setting may be mediated by the
volume receptor function (22). The essential hypernatremia
represents a selective damage to the osmoreceptors resulting
in hypodipsia, hypernatremia, and volume-mediated AVP
release. This hypothesis has been confirmed in at least one
patient whose plasma ADH levels increased normally with
correction of hypotension, but changed little with an eleva-
tion in plasma osmolality (27).
Our case shows that the dissociation of hypodipsia from
hy-povasopressinemia indicates the neuronal pathways that
mediate osmoregulation of thirst and vasopressin secretion
in humans are sufficiently discrete to be affected selectively.
Whether this anatomical separation begins at the level of
the osmoreceptors themselves or occurs further on in the
efferent pathway is unknown. However, the functional dis-
Oct.22 Oct.25 Oct.27 Nov.5 Nov.6 Nov.8 Nov.11 Nov.13
Table 3. Changes in serum electrolytes, renin and aldosterone levels
Serum K (mEq/L) 2.78 3.7 3.9 3.7 3.8 3.4 3.4 3.4
Serum Na (mEq/L) 172 155 148 155 149 145 147 149
TTKG 6.2 7.7 9.7 7.1 6.3
PRA (ng/mL/hr) basal/stimulated 3.99 8.05/14.93 7.39
Aldosterone (pg/mL) basal/stimulated 47.15 103.88/274.04 33.85
Hypokalemia might be due to the activation of renin-angiotensin-aldosterone system (TTKG>4). We can observe parallel fluctuation of serum sodium
and aldosterone concentrations during the follow-up period. These findings suggest that hypernateremia could play a permissive role in aldosterone
secretion, which is the normal response to renin. Samples for PRA and plasma aldosterone are obtained after supine position for 30 min and uplight
posture for 4 hr.Hypodipsic Hypernatremia 681
sociation does indicate that defects in one osmoregulatory
system need not be accompanied by an abnormality in the
other (28).
In hypodipsic hypernatremia, the symptoms of chronic
hypernatremia itself may be absent. However, the underly-
ing neurologic disease frequently precedes the onset of hy-
pernatremia, and it may be difficult to tell initially whether
the neurologic abnormalities are in fact due to the increase
in plasma Na
+ concentration. For example, patients with
hypodipsia and essential hypernatremia have hypothalamic
lesions which may be due to tumors. In the diagnosis of
hypodipsic hypernatremia, the most important point is that
there is no spontaneous drinking despite hyperosmolar state.
Other helpful diagnostic tests, although not confirmed, are
water restriction test and hypertonic saline infusion test. Up
to present, there has been no confirmatory diagnostic test.
The proper treatment for patients with hypothalamic dys-
function with normal AVP secretion can be simply forcing the
patient to drink water. Patient can be instructed to drink
1,500 to 2,000 mL of water per day, regardless of thirst.
Correction of hypernatremia is somewhat more difficult in
hypodipsic patients with completely impaired AVP secre-
tion. In these conditions, a water loading only induces
polyuria, and hypernartremia will be sustained. Chloro-
propamide, which enhances the action of the small amount
of AVP being released, has proven to be effective in these
patients. However, there is some risk of hyponatremia, since
the osmoreceptor defect may prevent complete suppression
of AVP release after a water load (22).
Dunger et al. presented the first direct evidence for increa-
sed renal sensitivity to exogenous AVP in patients with
essential hypernatremia. DDAVP administered to the pa-
tients for 3 months showed a return of this response toward
normal, and they also reported that treatment with DDAVP
led to a sensation of thirst (13). In this case, we did not try
DDAVP to rekindle the sense of thirst because hyperna-
tremia was well controlled with intentional water intake
only and the use of DDAVP might have led to hypona-
tremia.
We report a case of hypodipsic hypernatremia induced by
selective defects of AVP secretory response to hyperosmolal-
ity due to brain tumor. In this patient, AVP response to non-
osmotic stimuli was well preserved but hypothalamic hypo-
pituitarism and impaired serum ANP regulation were ob-
served.
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